#5 - A Case Study on Deprescribing Desvenlafaxine.

Welcome to the fifth episode of Deprescribe with Shawn. Today’s episode is a recording of a case presentation I gave for the University of British Columbia’s Therapeutics Initiative, in July 2024. I presented a patient case on deprescribing desvenlafaxine (brand name: Pritiq) using hyperbolic tapering.To learn more about my presentation with Therapeutics Initiative, click here. To access the slides from the webinar, click here.Connect with Shawn:LinkedIn | Twitter/X | Personal Site | InstagramAlternate links and other platforms you can watch/listen on:How To Support The ShowIf you want to support me there are 2 ways you can for free* Give this podcast a 5-star rating on Spotify or Apple Podcasts* Share this with anyone you think would enjoy thisIf you have any questions, please comment below, or you can connect with me on LinkedIn!If you enjoyed this podcast episode, please consider subscribing to the channel and sharing the episode. Many thanks.B.U.D.S is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.Build. Understand. Discipline. Stillness. “B.U.D.S” is written by me, Dr. Shawn Gill - I’m a pharmacist and Father of two boys. During the day, I work as a deprescribing pharmacist, helping patients get off drugs, safely and effectively. At night, I write this newsletter. B.U.D.S is a community focused on inspiring individuals to take account of their health and wellness, as well as reverse mental health and chronic disease. If you’d like to support this mission, please subscribe below. Much love. SG Get full access to B.U.D.S at shawngill.substack.com/subscribe